Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Weiss

Showing results (11-20 of 257) with videos related to

Pageof 26
Sort By:
Muscle & Nerve|June 14, 2012
Rituximab therapy for Morvan syndrome associated with myasthenia gravisMichael Weiss
Expert Opinion on Drug Metabolism & Toxicology|August 30, 2011
Functional characterization of drug uptake and metabolism in the heartMichael Weiss
Journal of Applied Physiology (Bethesda, Md. : 1985)|June 6, 2009
Cardiac output and systemic transit time dispersion as determinants of circulatory mixing time: a simulation studyMichael Weiss
Journal of Pharmacokinetics and Pharmacodynamics|February 3, 2017
Empirical models for fitting of oral concentration time curves with and without an intravenous referenceMichael Weiss
Journal of Occupational and Environmental Medicine|November 10, 2004
Preplacement nerve testing for carpal tunnel syndromeMichael Weiss
Pharmaceutical Research|May 19, 2007
Residence time dispersion as a general measure of drug distribution kinetics: estimation and physiological interpretationMichael Weiss
European Journal of Drug Metabolism and Pharmacokinetics|January 16, 2023
Relationship Between Dissolution Rate in Vitro and Absorption Rate in Vivo of Ketamine Prolonged-Release TabletsMichael Weiss
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 9, 2014
Modeling accelerated and decelerated drug release in terms of fractional release rateMichael Weiss
The Journal of Pharmacology and Experimental Therapeutics|January 24, 2002
P-glycoprotein inhibitors enhance saturable uptake of idarubicin in rat heart: pharmacokinetic/pharmacodynamic modelingMichael Weiss, Wonku Kang
Clinical Pharmacology in Drug Development|July 15, 2021
Pharmacokinetic Modeling of Ketamine Enantiomers and Their Metabolites After Administration of Prolonged-Release Ketamine With Emphasis on 2,6-HydroxynorketaminesMichael Weiss, Werner Siegmund
Pageof 26

Showing results (11-20 of 257) with videos related to

Sort By:
Pageof 26
Muscle & Nerve|June 14, 2012
Rituximab therapy for Morvan syndrome associated with myasthenia gravisMichael Weiss
Expert Opinion on Drug Metabolism & Toxicology|August 30, 2011
Functional characterization of drug uptake and metabolism in the heartMichael Weiss
Journal of Applied Physiology (Bethesda, Md. : 1985)|June 6, 2009
Cardiac output and systemic transit time dispersion as determinants of circulatory mixing time: a simulation studyMichael Weiss
Journal of Pharmacokinetics and Pharmacodynamics|February 3, 2017
Empirical models for fitting of oral concentration time curves with and without an intravenous referenceMichael Weiss
Journal of Occupational and Environmental Medicine|November 10, 2004
Preplacement nerve testing for carpal tunnel syndromeMichael Weiss
Pharmaceutical Research|May 19, 2007
Residence time dispersion as a general measure of drug distribution kinetics: estimation and physiological interpretationMichael Weiss
European Journal of Drug Metabolism and Pharmacokinetics|January 16, 2023
Relationship Between Dissolution Rate in Vitro and Absorption Rate in Vivo of Ketamine Prolonged-Release TabletsMichael Weiss
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 9, 2014
Modeling accelerated and decelerated drug release in terms of fractional release rateMichael Weiss
The Journal of Pharmacology and Experimental Therapeutics|January 24, 2002
P-glycoprotein inhibitors enhance saturable uptake of idarubicin in rat heart: pharmacokinetic/pharmacodynamic modelingMichael Weiss, Wonku Kang
Clinical Pharmacology in Drug Development|July 15, 2021
Pharmacokinetic Modeling of Ketamine Enantiomers and Their Metabolites After Administration of Prolonged-Release Ketamine With Emphasis on 2,6-HydroxynorketaminesMichael Weiss, Werner Siegmund
Pageof 26